Stock detail
Viking Therapeutics (VKTX) stock price, chart, and key data
View Viking Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Viking Therapeutics
VKTX · XNAS
$26.86
0.00%
$0.00
Pre-market $26.53 (-1.23%)
Key metrics
52-week range
$15.50 - $12.00
Close price
$26.86
Market cap
$3.2B
P/E ratio
-24.42
Beta
0.83
About the company
Viking Therapeutics Inc
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$92.59
17
Buy
/ 18
Recent calls
10/29/2026
Stifel Nicolaus
Annabel Samimy
Buy · Price target $95.00
10/28/2026
Cantor Fitzgerald
Steven Seedhouse
Buy · Price target $100
10/29/2026
Leerink Partners
Unknown Analyst
Buy · Price target $118
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app